Zollinger-Ellison syndrome epidemiology and demographics: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
The incidence of [[gastrinoma]], which can cause Zollinger-Ellison syndrome, is approximately 0.05-0.2 per 100,000 individuals worldwide. About 25 to 30 percent of gastrinomas are caused by multiple endocrine neoplasia type 1 ([[MEN1]]). | The incidence of [[gastrinoma]], which can cause Zollinger-Ellison syndrome, is approximately 0.05-0.2 per 100,000 individuals worldwide. About 25 to 30 percent of gastrinomas are caused by multiple endocrine neoplasia type 1 ([[MEN1]]). | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 15:21, 1 August 2017
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome epidemiology and demographics |
|
FDA on Zollinger-Ellison syndrome epidemiology and demographics |
|
CDC on Zollinger-Ellison syndrome epidemiology and demographics |
|
Zollinger-Ellison syndrome epidemiology and demographics in the news |
|
Blogs on Zollinger-Ellison syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The incidence of gastrinoma, which can cause Zollinger-Ellison syndrome, is approximately 0.05-0.2 per 100,000 individuals worldwide. About 25 to 30 percent of gastrinomas are caused by multiple endocrine neoplasia type 1 (MEN1).
Epidemiology and Demographics
Incidence
- The incidence of gastrinoma, which can cause Zollinger-Ellison syndrome, is approximately 0.5-2 persons per 100,000 individuals worldwide.[1]
Age
- Zollinger-Ellison syndrome is a disease that tends to affect the middle-aged adult population (20-50 years of age).[2]
Gender
- Males are more commonly affected with Zollinger-Ellison syndrome than females.[2]
References
- ↑ Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P; et al. (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes". Neuroendocrinology. 95 (2): 98–119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
- ↑ 2.0 2.1 Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT (2006). "Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature". Medicine (Baltimore). 85 (6): 295–330. doi:10.1097/01.md.0000236956.74128.76. PMID 17108778.